Literature DB >> 3342405

Loss of metastatic responsiveness to cell shape modulation in a newly characterized B16 melanoma adhesive cell variant.

I R Nabi1, A Raz.   

Abstract

Repeated selection of an adherent subpopulation from B16-F1 melanoma cells growing in suspension culture on poly(hydroxyethylmethacrylate) [poly(HEMA)] coated plates resulted in the isolation of an adherent variant designated B16-A10. B16-A10 cells are more adherent to poly(hydroxyethylmethacrylate) coated plates than are B16-F1 cells and express an organized actin structure characteristic of highly adherent low metastatic cells as opposed to the poor cytoskeletal organization of B16-F1 cells. Upon growth in suspension, B16-A10 cells do not acquire the enhanced metastatic capability characteristic of B16-F1 cells and they express similar lung colonizing ability irrespective of the culture conditions. The increased metastatic ability of B16-F1 cells in suspension culture has previously been associated with the decreased accessibility of surface proteins to lactoperoxidase catalyzed iodination and with the increased expression of sialylated peanut agglutinin-binding oligosaccharides on these proteins. B16-A10 cells which show no cell shape induced increase in metastatic ability do not undergo alteration in either of these two properties in suspension culture. The absence of these two phenomena on B16-A10 cells grown in suspension indicates that they are interrelated and involved in the increased metastatic ability of B16-F1 cells grown in suspension.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3342405

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  Cell migration and actin organization in cultured human primary, recurrent cutaneous and metastatic melanoma. Time-lapse and image analysis.

Authors:  H R Byers; T Etoh; J R Doherty; A J Sober; M C Mihm
Journal:  Am J Pathol       Date:  1991-08       Impact factor: 4.307

Review 2.  Technical considerations for studying cancer metastasis in vivo.

Authors:  D R Welch
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

3.  Purification of two glycoproteins expressing beta 1-6 branched Asn-linked oligosaccharides from metastatic tumour cells.

Authors:  S Laferte; J W Dennis
Journal:  Biochem J       Date:  1989-04-15       Impact factor: 3.857

Review 4.  Autocrine factors, type IV collagenase secretion and prostatic cancer cell invasion.

Authors:  M E Stearns; M Stearns
Journal:  Cancer Metastasis Rev       Date:  1993-03       Impact factor: 9.264

Review 5.  Autocrine motility factor and its receptor: role in cell locomotion and metastasis.

Authors:  I R Nabi; H Watanabe; A Raz
Journal:  Cancer Metastasis Rev       Date:  1992-03       Impact factor: 9.264

6.  Autocrine motility factor stimulates the invasiveness of malignant cells as well as up-regulation of matrix metalloproteinase-3 expression via a MAPK pathway.

Authors:  Arayo Haga; Tatsuyoshi Funasaka; Yoshihiro Deyashiki; Avraham Raz
Journal:  FEBS Lett       Date:  2008-05-15       Impact factor: 4.124

7.  Autocrine motility factor receptor is a marker for a distinct membranous tubular organelle.

Authors:  N Benlimame; D Simard; I R Nabi
Journal:  J Cell Biol       Date:  1995-04       Impact factor: 10.539

8.  Raft-dependent endocytosis of autocrine motility factor/phosphoglucose isomerase: a potential drug delivery route for tumor cells.

Authors:  Liliana D Kojic; Sam M Wiseman; Fariba Ghaidi; Bharat Joshi; Hinyu Nedev; H Uri Saragovi; Ivan R Nabi
Journal:  PLoS One       Date:  2008-10-31       Impact factor: 3.240

9.  p38 MAP kinase-dependent phosphorylation of the Gp78 E3 ubiquitin ligase controls ER-mitochondria association and mitochondria motility.

Authors:  Lei Li; Guang Gao; Jay Shankar; Bharat Joshi; Leonard J Foster; Ivan R Nabi
Journal:  Mol Biol Cell       Date:  2015-09-02       Impact factor: 4.138

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.